Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 12 January 2021
EventHumanCOVID-19
Date
- Tuesday, 12 January 2021, All day
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary meeting is planned in the context of the evaluation of the COVID-19 vaccine mRNA-1273 developed by Moderna.
The aim of the meeting will be to conclude the evaluation, if this is not possible at the CHMP’s extraordinary meeting on 6 January.
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.